Article Details

Cue Biopharma, Inc. Reports New Complete Response and Confirms 50 ... - MarketScreener

Retrieved on: 2025-07-16 20:54:01

Tags for this article:

Click the tags to see associated articles and topics

Cue Biopharma, Inc. Reports New Complete Response and Confirms 50 ... - MarketScreener. View article details on hiswai:

Excerpt

Cue Biopharma, Inc. Reports New Complete Response and Confirms 50% Overall Response Rate in Ongoing Phase 1 Trial of CUE-101 and Pembrolizumab in ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo